Pharmacological Treatments for COVID-19
Vikrant Gupta
Published: October 01, 2021.
Abstract
Coronavirus disease 2019 (COVID-19) was initially reported in December 2019 in China and cause an acute respiratory disease. Since then, no specific therapy or vaccine is being available for the treatment or prevention of the disease. Teams of scientists around the world are racing to develop a treatment to end the COVID-19 pandemic. Extensive clinical trial data are required to identify safe and effective treatments for COVID-19. In this review, we aim to provide an overview of antiviral drugs, their pharmacological features, and their outcome against the disease based on the available data. We have discussed their mechanism of action, doses, and adverse effects in detail. In addition, a close review of vaccines that are in the developmental state has also been discussed.